Jason Lettmann sold $2,483 of ALXO
CHIEF EXECUTIVE OFFICER at ALX ONCOLOGY HOLDINGS INC. 2,159 shares at an average of $1.15, traded Feb 19, 2025, filed Feb 21, 2025.
Score components
- +25RoleCEO
- 0Trade size$2k at market
- 0Share of holdings soldSold 1.3% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-005067, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 19, 2025 | SOpen-market sale Common Stock | -2,159 | $1.15 | $2,483 | 170,270 | Feb 21, 2025 |
Related signals
Other insiders at ALX ONCOLOGY HOLDINGS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | ALX ONCOLOGY HOLDINGS INC | Shelly Pinto SVP, FINANCE AND CAO | $1,960 903 shares | -1% | |
| 38Weak | ALX ONCOLOGY HOLDINGS INC | Jason Lettmann CHIEF EXECUTIVE OFFICER | $27k 12,311 shares | -4% | |
| 15Weak | ALXOsell ALX ONCOLOGY HOLDINGS INC | Shelly Pinto SVP, FINANCE AND CAO | $1,283 565 shares | -1% | |
| 54Moderate | ALXObuy ALX ONCOLOGY HOLDINGS INC | Corey S Goodman director, owner | $5.0M 3,184,713 shares | +60% | |
| 15Weak | ALXOsell ALX ONCOLOGY HOLDINGS INC | Shelly Pinto SVP, FINANCE AND CAO | $4,357 3,925 shares | -4% | |
| 49Moderate | ALXObuy ALX ONCOLOGY HOLDINGS INC | Jason Lettmann CHIEF EXECUTIVE OFFICER | $99k 92,233 shares | +43% | |
| 45Moderate | ALXObuy ALX ONCOLOGY HOLDINGS INC | Harish Shantharam Chief Financial Officer | $58k 75,000 shares | - | |
| 33Weak | ALX ONCOLOGY HOLDINGS INC | Jason Lettmann CHIEF EXECUTIVE OFFICER | $1,525 2,382 shares | -1% | |
| 23Weak | ALX ONCOLOGY HOLDINGS INC | Shelly Pinto SVP, FINANCE AND CAO | $391 611 shares | -1% | |
| 15Weak | ALXOsell ALX ONCOLOGY HOLDINGS INC | Shelly Pinto SVP, FINANCE AND CAO | $905 2,011 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.